Details for New Drug Application (NDA): 011891
✉ Email this page to a colleague
NDA 011891 describes DURABOLIN, which is a drug marketed by Organon Usa Inc and is included in one NDA. Additional details are available on the DURABOLIN profile page.
The generic ingredient in DURABOLIN is nandrolone phenpropionate. There are fifteen drug master file entries for this compound. Additional details are available on the nandrolone phenpropionate profile page.
The generic ingredient in DURABOLIN is nandrolone phenpropionate. There are fifteen drug master file entries for this compound. Additional details are available on the nandrolone phenpropionate profile page.
Summary for 011891
| Tradename: | DURABOLIN |
| Applicant: | Organon Usa Inc |
| Ingredient: | nandrolone phenpropionate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 25MG/ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 50MG/ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
